These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 950097)

  • 1. Effects of anticopper therapy on hepatocellular mitochondria in patients with Wilson's disease: an ultrastructural and stereological study.
    Sternlieb I; Feldmann G
    Gastroenterology; 1976 Sep; 71(3):457-61. PubMed ID: 950097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermal alterations in patients with Wilson's disease treated with D-penicillamine.
    Pasquali Ronchetti I; Quaglino D; Baccarani Contri M; Hayek J; Galassi G
    J Submicrosc Cytol Pathol; 1989 Jan; 21(1):131-9. PubMed ID: 2702608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural pathology with normal light microscopy of liver in Wilson's disease. A case report.
    Enat R; Lichtig C; Segman S; Hemli JA; Barzilai D
    Isr J Med Sci; 1979 Jun; 15(6):485-9. PubMed ID: 457381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [2 cases of Wilson's disease diagnosed at the infra-clinical stage. Prolonged, early treatment using penicillamine. Result].
    Hamza B; el-Kamel M
    Tunis Med; 1974; 52(1):29-31. PubMed ID: 4215182
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipolysosomes in human hepatocytes. Ultrastructural and cytochemical studies of patients with Wilson's disease.
    Hayashi H; Sternlieb I
    Lab Invest; 1975 Jul; 33(1):1-7. PubMed ID: 1142738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Wilson's disease in asymptomatic patients.
    Sternlieb I; Scheinberg IH
    N Engl J Med; 1968 Feb; 278(7):352-9. PubMed ID: 5635646
    [No Abstract]   [Full Text] [Related]  

  • 7. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 8. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
    Giacchino R; Marazzi MG; Barabino A; Fasce L; Ciravegna B; Famularo L; Boni L; Callea F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):155-61. PubMed ID: 9646197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial and fatty changes in hepatocytes of patients with Wilson's disease.
    Sternlieb I
    Gastroenterology; 1968 Sep; 55(3):354-67. PubMed ID: 5675366
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron accumulation in the liver of male patients with Wilson's disease.
    Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
    Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc and tetrathiomolybdate for the treatment of Wilson's disease and the potential efficacy of anticopper therapy in a wide variety of diseases.
    Brewer GJ
    Metallomics; 2009; 1(3):199-206. PubMed ID: 21305118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
    J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z; Heyrovský A; Volek V
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An array of mitochondrial alterations in the hepatocytes of Long-Evans Cinnamon rats.
    Sternlieb I; Quintana N; Volenberg I; Schilsky ML
    Hepatology; 1995 Dec; 22(6):1782-7. PubMed ID: 7489989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoceruloplasminemia and ultrastructural changes resembling Wilson's disease in nonalcoholic liver steatosis. A clinical and pathological study of five cases.
    Geubel AP; Gregoire V; Rahier J; Lissens W; Dive C
    Liver; 1988 Oct; 8(5):299-306. PubMed ID: 3200124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S; Samuelson G; Sjölin S
    Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the therapeutic combination of S-adenosylmethionine with D-penicillamine in Wilson's disease].
    Gasbarrini G; Miglio F; Corazza GR; Stefanini GF
    Minerva Med; 1975 May; 66(33):1600-4. PubMed ID: 1143693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.